Merck KGaA (MKGAF)
183.00
+3.00
(+1.67%)
USD |
OTCM |
May 20, 16:00
Merck Price to Book Value: 2.632 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.589 |
| May 16, 2024 | 2.624 |
| May 15, 2024 | 2.525 |
| May 14, 2024 | 2.485 |
| May 13, 2024 | 2.363 |
| May 10, 2024 | 2.421 |
| May 09, 2024 | 2.379 |
| May 08, 2024 | 2.375 |
| May 07, 2024 | 2.427 |
| May 06, 2024 | 2.340 |
| May 03, 2024 | 2.333 |
| May 02, 2024 | 2.330 |
| May 01, 2024 | 2.216 |
| April 30, 2024 | 2.315 |
| April 29, 2024 | 2.348 |
| April 26, 2024 | 2.259 |
| April 25, 2024 | 2.378 |
| April 24, 2024 | 2.277 |
| April 23, 2024 | 2.308 |
| April 22, 2024 | 2.243 |
| April 19, 2024 | 2.243 |
| April 18, 2024 | 2.283 |
| April 17, 2024 | 2.283 |
| April 16, 2024 | 2.335 |
| April 15, 2024 | 2.330 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.351 |
| April 11, 2024 | 2.371 |
| April 10, 2024 | 2.322 |
| April 09, 2024 | 2.420 |
| April 08, 2024 | 2.339 |
| April 05, 2024 | 2.330 |
| April 04, 2024 | 2.432 |
| April 03, 2024 | 2.466 |
| April 02, 2024 | 2.434 |
| April 01, 2024 | 2.538 |
| March 31, 2024 | |
| March 28, 2024 | 2.607 |
| March 27, 2024 | 2.568 |
| March 26, 2024 | 2.542 |
| March 25, 2024 | 2.565 |
| March 22, 2024 | 2.524 |
| March 21, 2024 | 2.587 |
| March 20, 2024 | 2.479 |
| March 19, 2024 | 2.521 |
| March 18, 2024 | 2.514 |
| March 15, 2024 | 2.578 |
| March 14, 2024 | 2.558 |
| March 13, 2024 | 2.590 |
| March 12, 2024 | 2.595 |
| March 11, 2024 | 2.532 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.805
Minimum
Mar 18 2020
4.778
Maximum
Dec 27 2021
2.978
Average
2.810
Median
Jul 27 2020
Price to Book Value Benchmarks
| Affimed NV | 1.238 |
| InflaRx NV | 0.8861 |
| MorphoSys AG | 51.62 |
| BioNTech SE | 1.033 |
Price to Book Value Related Metrics
| PE Ratio | 26.92 |
| PS Ratio | 3.519 |
| Price to Free Cash Flow | 40.25 |
| Price | 183.00 |
| Earnings Yield | 3.71% |
| Market Cap | 79.56B |
| Operating PE Ratio | 21.08 |
| Normalized PE Ratio | 27.11 |